Ryan D. Maynard

2015

In 2015, Ryan D. Maynard earned a total compensation of $1.1M as Executive Vice President, Chief Financial Officer at Rigel Pharmaceuticals, a 1% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$187,571
Option Awards$476,735
Salary$441,345
Other$1,170
Total$1,106,821

Maynard received $476.7K in option awards, accounting for 43% of the total pay in 2015.

Maynard also received $187.6K in non-equity incentive plan, $441.3K in salary and $1.2K in other compensation.

Rankings

In 2015, Ryan D. Maynard's compensation ranked 7,457th out of 13,638 executives tracked by ExecPay. In other words, Maynard earned more than 45.3% of executives.

ClassificationRankingPercentile
All
7,457
out of 13,638
45th
Division
Manufacturing
2,814
out of 5,190
46th
Major group
Chemicals And Allied Products
1,018
out of 1,854
45th
Industry group
Drugs
820
out of 1,528
46th
Industry
Pharmaceutical Preparations
644
out of 1,182
46th
Source: SEC filing on March 29, 2017.

Maynard's colleagues

We found four more compensation records of executives who worked with Ryan D. Maynard at Rigel Pharmaceuticals in 2015.

2015

Raul Rodriguez

Rigel Pharmaceuticals

Chief Executive Officer

2015

Donald Payan

Rigel Pharmaceuticals

Executive Vice President, of Discovery and Research

2015

Elliott Grossbard

Rigel Pharmaceuticals

Chief Medical Officer

2015

Dolly Vance

Rigel Pharmaceuticals

General Counsel

You may also like